论文部分内容阅读
2013年2月6日,国家食品药品监督管理局发布第52期《药品不良反应信息通报》,关注红花注射液引起严重不良反应。据《通报》,红花注射液的主要成分是红花。用于治疗闭塞性脑血管疾病、冠心病、脉管炎。2012年,国家药品不良反应监测数据库中有关红花注射液的病例报告数共计3306例,严重
On February 6, 2013, the State Food and Drug Administration released the 52nd “Information Bulletin on Adverse Drug Reactions,” and noted that safflower injection caused serious adverse reactions. According to “Bulletin”, the main component of safflower injection is safflower. For the treatment of occlusive cerebrovascular disease, coronary heart disease, vasculitis. In 2012, a total of 3,306 cases of safflor injection were reported in the national ADR monitoring database,